Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | decaprenyl diphosphate synthase subunit 1 | 0.0171 | 0.1236 | 0.0534 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.5 |
Plasmodium falciparum | geranylgeranyl pyrophosphate synthase, putative | 0.0678 | 1 | 1 |
Echinococcus granulosus | prenyl decaprenyl diphosphate synthase | 0.0171 | 0.1236 | 0.0534 |
Chlamydia trachomatis | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.5 |
Echinococcus granulosus | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.0534 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Entamoeba histolytica | bifunctional short chain isoprenyl diphosphate synthase, putative | 0.0171 | 0.1236 | 0.5 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase, putative | 0.0678 | 1 | 1 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthetase, putative | 0.0171 | 0.1236 | 0.5 |
Giardia lamblia | Farnesyl diphosphate synthase | 0.0678 | 1 | 0.5 |
Mycobacterium leprae | PROBABLE POLYPRENYL-DIPHOSPHATE SYNTHASE GRCC1 (POLYPRENYL PYROPHOSPHATE SYNTHETASE) | 0.0171 | 0.1236 | 0.5 |
Treponema pallidum | octaprenyl-diphosphate synthase | 0.0171 | 0.1236 | 0.5 |
Echinococcus granulosus | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Schistosoma mansoni | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.1236 |
Leishmania major | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthase, putative | 0.0171 | 0.1236 | 0.5 |
Schistosoma mansoni | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Echinococcus multilocularis | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.0534 |
Echinococcus granulosus | decaprenyl diphosphate synthase subunit 1 | 0.0171 | 0.1236 | 0.0534 |
Schistosoma mansoni | lipoxygenase | 0.0142 | 0.0741 | 0.0741 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0678 | 1 | 0.5 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.0678 | 1 | 1 |
Echinococcus multilocularis | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.0678 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0678 | 1 | 0.5 |
Trypanosoma brucei | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0542 | 0.7651 | 0.7651 |
Trichomonas vaginalis | geranylgeranyl diphosphate synthase, putative | 0.0678 | 1 | 0.5 |
Schistosoma mansoni | trans-prenyltransferase | 0.0171 | 0.1236 | 0.1236 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Plasmodium vivax | geranylgeranyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Schistosoma mansoni | glutathione synthetase | 0.0171 | 0.1236 | 0.1236 |
Echinococcus multilocularis | prenyl (decaprenyl) diphosphate synthase | 0.0171 | 0.1236 | 0.0534 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.5 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0678 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 14 % | The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 30 microM | ChEMBL. | No reference |
Inhibition (binding) | = 14 % | The compound was evaluated in vitro for inhibition of 5-lipoxygenase activity in RBL-1 cells at 30 microM | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.